Form 8-K - Current report:
SEC Accession No. 0001477932-19-002667
Filing Date
2019-05-14
Accepted
2019-05-14 14:33:57
Documents
2
Period of Report
2019-05-14
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K curr_8k.htm 8-K 20077
2 PRESS RELEASE curr_ex991.htm EX-99.1 6640
  Complete submission text file 0001477932-19-002667.txt   28142
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Filer) CIK: 0001643301 (see all company filings)

IRS No.: 371765151 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55908 | Film No.: 19822158
SIC: 2673 Plastics, Foil & Coated Paper Bags